U.S. Physical Therapy, Inc. $USPH Shares Sold by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. lowered its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 12.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 22,332 shares of the company’s stock after selling 3,256 shares during the quarter. Oppenheimer Asset Management Inc. owned approximately 0.15% of U.S. Physical Therapy worth $1,746,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of USPH. Copeland Capital Management LLC lifted its position in U.S. Physical Therapy by 8.9% in the second quarter. Copeland Capital Management LLC now owns 888,735 shares of the company’s stock valued at $69,499,000 after acquiring an additional 72,463 shares during the last quarter. Bahl & Gaynor Inc. grew its holdings in shares of U.S. Physical Therapy by 32.6% during the first quarter. Bahl & Gaynor Inc. now owns 345,003 shares of the company’s stock worth $24,964,000 after purchasing an additional 84,878 shares during the last quarter. GW&K Investment Management LLC increased its position in shares of U.S. Physical Therapy by 8.9% during the first quarter. GW&K Investment Management LLC now owns 344,390 shares of the company’s stock worth $24,920,000 after purchasing an additional 28,203 shares in the last quarter. Envestnet Asset Management Inc. lifted its holdings in shares of U.S. Physical Therapy by 5.6% in the 1st quarter. Envestnet Asset Management Inc. now owns 316,489 shares of the company’s stock valued at $22,901,000 after purchasing an additional 16,698 shares during the last quarter. Finally, Northern Trust Corp lifted its holdings in shares of U.S. Physical Therapy by 4.7% in the 1st quarter. Northern Trust Corp now owns 274,117 shares of the company’s stock valued at $19,835,000 after purchasing an additional 12,292 shares during the last quarter.

U.S. Physical Therapy Stock Performance

NYSE:USPH opened at $86.37 on Friday. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $101.19. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of 37.72, a price-to-earnings-growth ratio of 4.41 and a beta of 1.48. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.18. The firm’s fifty day moving average price is $85.59 and its 200 day moving average price is $79.36.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Tuesday, August 22nd. The company reported $0.90 earnings per share for the quarter. The business had revenue of $140.66 million for the quarter. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. On average, sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 12th. Shareholders of record on Friday, August 22nd were given a dividend of $0.45 per share. The ex-dividend date was Friday, August 22nd. This represents a $1.80 annualized dividend and a yield of 2.1%. U.S. Physical Therapy’s payout ratio is presently 78.60%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Eric Joseph Williams sold 1,000 shares of the stock in a transaction on Friday, September 5th. The stock was sold at an average price of $85.25, for a total value of $85,250.00. Following the completion of the transaction, the chief operating officer owned 25,331 shares in the company, valued at approximately $2,159,467.75. This represents a 3.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Carey P. Hendrickson sold 698 shares of the firm’s stock in a transaction on Monday, August 25th. The shares were sold at an average price of $86.11, for a total value of $60,104.78. Following the completion of the sale, the chief financial officer directly owned 27,808 shares of the company’s stock, valued at approximately $2,394,546.88. This trade represents a 2.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 6,853 shares of company stock worth $581,406. 2.00% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on USPH shares. Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, October 8th. Wall Street Zen downgraded U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Sunday, September 21st. Zacks Research upgraded shares of U.S. Physical Therapy to a “hold” rating in a research report on Friday, August 8th. JPMorgan Chase & Co. began coverage on shares of U.S. Physical Therapy in a research report on Thursday, September 18th. They issued an “overweight” rating and a $110.00 price target for the company. Finally, Barrington Research reiterated an “outperform” rating and set a $103.00 price target on shares of U.S. Physical Therapy in a research note on Friday, October 24th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, U.S. Physical Therapy has an average rating of “Moderate Buy” and a consensus price target of $110.25.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.